2019
DOI: 10.1016/j.ijpharm.2019.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Data reconciliation in the Quality-by-Design (QbD) implementation of pharmaceutical continuous tablet manufacturing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
2
2

Relationship

2
6

Authors

Journals

citations
Cited by 35 publications
(14 citation statements)
references
References 46 publications
0
14
0
Order By: Relevance
“…The QTPP may include dosage form, intended use in the clinical, delivery system, route of administration, the strength of dosage form, container and closure system, factors affecting pharmacokinetics (dissolution), quality criteria of drug product like stability, purity and drug release [4] . Identification of QTPP is followed by the identification of factors which may instigate the QTPP and to further analyze those which do so perilously [5] . These factors are the Critical Quality Attributes (CQAs) of product which eminently depends on the Critical Material Attributes (CMAs) of excipient used in product development along with Critical Process Parameters (CPPs) during manufacturing [6] .…”
Section: Computationalmentioning
confidence: 99%
“…The QTPP may include dosage form, intended use in the clinical, delivery system, route of administration, the strength of dosage form, container and closure system, factors affecting pharmacokinetics (dissolution), quality criteria of drug product like stability, purity and drug release [4] . Identification of QTPP is followed by the identification of factors which may instigate the QTPP and to further analyze those which do so perilously [5] . These factors are the Critical Quality Attributes (CQAs) of product which eminently depends on the Critical Material Attributes (CMAs) of excipient used in product development along with Critical Process Parameters (CPPs) during manufacturing [6] .…”
Section: Computationalmentioning
confidence: 99%
“…Therefore, models for glidant effects in die filling and compression processes will be used to monitor and control the porosity and tensile strength of tablets. Specifically, these mechanistic models capture the effects of glidant concentration and mixing conditions [61,62].…”
Section: Tablet Press Modelmentioning
confidence: 99%
“…The elastic recovery model is not sensitive to the glidant mixing conditions [61,62], and it is governed by:…”
Section: Tablet Press Modelmentioning
confidence: 99%
See 1 more Smart Citation
“…QTPP can be defined as "A prospective summary of the quality characteristics of a drug product that ideally will be achieved to ensure the desired quality, taking into account safety and efficacy of the drug" 12 . The second step involves the identification of factors which may influence QTPP 13 . These are called critical quality attributes of the product (CQAs).…”
mentioning
confidence: 99%